Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease
Predictions From The Product Development Front Line
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
